Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by brain accumulation of amyloid-β peptide and neurofibrillary tangles, which are believed to initiate a pathological cascade that results in progressive impairment of cognitive functions and eventual neuronal death. To obtain a mouse model displaying the typical AD histopathology of amyloidosis and tauopathy, we generated a triple-transgenic mouse line (TauPS2APP) by overexpressing human mutations of the amyloid precursor protein, presenilin2 and tau genes. Stereological analysis of TauPS2APP mice revealed significant neurodegeneration of GABAergic septo-hippocampal projection neurons as well as their target cells, the GABAergic hippocampal interneurons. In contrast, the cholinergic medial septum neurons remained unaffected. Moreover, the degeneration of hippocampal GABAergic interneurons was dependent on the hippocampal subfield and interneuronal subtype investigated, whereby the dentate gyrus and the NPY-positive interneurons, respectively, were most strongly affected. Neurodegeneration was also accompanied by a change in the mRNA expression of markers for inhibitory interneurons. In line with the loss of inhibitory neurons, we observed functional changes in TauPS2APP mice relative to WT mice, with strongly enhanced long-term potentiation in the medial-perforant pathway input to the dentate gyrus, and stereotypic hyperactivity. Our data indicate that inhibitory neurons are the targets of neurodegeneration in a mouse model of amyloidosis and tauopathy, thus pointing to a possible role of the inhibitory network in the pathophysiological and functional cascade of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 2×
“In line with this, electron microscopic analysis of the expression level and distribution of glutamatergic receptors at excitatory input synapses of GABAergic interneurons together with single cell RT-PCR would be useful, since an alteration in NMDA-receptor distribution could activate pro-apoptotic pathways in intern…”
BackgroundPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 3×
“However, the alterations in the inhibitory network recorded in these studies resemble those seen after excitotoxic stimuli and might rather compensate for the overexcitability of the corticolimbic network (Palop et al., 2007).”
BackgroundFormation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · cited 2×
“Aβ peptides act upstream of tau and further stimulate hyperphosphorylation and tangle formation (Gotz et al., 2001b).”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · cited 3×
“AD is clinically divided into an early onset or familial (FAD) form, and a sporadic or late onset form (SAD).”
BackgroundGABA-containing neurons in the septum control inhibitory interneurons in the hippocampus
Freund, T. F., & Antal, M. (1988) · Nature · doi:10.1038/336170a0 · Cited by 1,283 · cited 1×
“The GABAergic septal projection terminates exclusively on inhibitory GABAergic interneurons in the hippocampus (Freund and Antal, 1988), which were observed to have undergone progressive degeneration in our TauPS2APP model.”
BackgroundDysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686 · cited 2×
“ison to age-matched, non-demented controls (Davis et al., 1999; DeKosky et al., 2002; Gilmor et al., 1999; Tiraboschi et al., 2000).”
ResultThe genetic epidemiology of neurodegenerative disease
Bertram, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24761 · Cited by 680 · cited 1×
“FAD is associatedwith geneticmutations in amyloid precursor protein (APP) and presenilin (PS) 1 or 2 (Bertram and Tanzi, 2005; Goate, 2006; Sherrington et al., 1995), makingmodels based on these human mutations highly relevant for investigations on the pathophysiology of FAD.”
BackgroundAnimal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · cited 1×
“Moreover, mice overexpressing mutated forms of tau show neurofibrillary pathology and neurodegeneration (Götz and Ittner, 2008).”
BackgroundLinking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · cited 1×
“Depletion of tau was sufficient to rescue this phenotype, suggesting a tau-dependent mechanism (Brecht et al., 2004; Harris et al., 2004; Small and Duff, 2008).”
BackgroundTau filament formation in transgenic mice expressing P301L tau
Götz, J., Chen, F., Barmettler, R., & Nitsch, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006531200 · Cited by 495 · cited 2×
“Aβ peptides act upstream of tau and further stimulate hyperphosphorylation and tangle formation (Gotz et al., 2001b).”
BackgroundBrecht, W. J., Harris, F. M., Chang, S., Tesseur, I., Yu, G.-Q., Xu, Q., Dee Fish, J., Wyss-Coray, T., Buttini, M., Mucke, L., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4315-03.2004 · Cited by 403 · cited 1×
“Depletion of tau was sufficient to rescue this phenotype, suggesting a tau-dependent mechanism (Brecht et al., 2004; Harris et al., 2004; Small and Duff, 2008).”
BackgroundAndrews-Zwilling, Y., Bien-Ly, N., Xu, Q., Li, G., Bernardo, A., Yoon, S. Y., Zwilling, D., Yan, T. X., Chen, L., & Huang, Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4040-10.2010 · Cited by 326
Buttini, M., Yu, G.-Q., Shockley, K., Huang, Y., Jones, B., Masliah, E., Mallory, M., Yeo, T., Longo, F. M., & Mucke, L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10539.2002 · Cited by 183 · cited 1×
“Thus, evidence based on some AD animal models suggests that any potential deficits within the cholinergic system do not make a primary contribution to the pathophysiology of AD (Buttini et al., 2002; Contestabile et al., 2008; German et al., 2003).”
BackgroundHarris, F. M., Brecht, W. J., Xu, Q., Mahley, R. W., & Huang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408127200 · Cited by 151 · cited 1×
“Depletion of tau was sufficient to rescue this phenotype, suggesting a tau-dependent mechanism (Brecht et al., 2004; Harris et al., 2004; Small and Duff, 2008).”
BackgroundParvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer’s diseased brain
Brady, D. R., & Mufson, E. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00068-7 · Cited by 125 · cited 1×
“Similarly, the numbers of PV-positive interneurons and NOS-positive small inhibitory interneurons in the hippocampus and cortex, respectively, are reduced in post mortem AD brains (Brady and Mufson, 1997; Koliatsos et al., 2006).”
BackgroundHippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease
Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124 · cited 2×
“…lines expressing human APP and/or PS1 mutations as a model for amyloidosis, a depletion in CALRET- and PV immunoreactivity was observed in the hippocampus, as determined by densitometry (Popović et al., 2008) and stereology (Baglietto-Vargas et al., 2010; Takahashi et al., 2010), respectively.”
MethodPhosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
Grueninger, F., Bohrmann, B., Czech, C., Ballard, T. M., Frey, J. R., Weidensteiner, C., von Kienlin, M., & Ozmen, L. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.004 · Cited by 117 · cited 10×
“Downregulation of markers for inhibitory transmission In an earlier study it was shown that principal neurons of the hippocampus are not affected by neurodegeneration (Grueninger et al., 2010).”
BackgroundMethodSelf-citationBaglietto-Vargas, D., Moreno-Gonzalez, I., Sanchez-Varo, R., Jimenez, S., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Romero-Acebal, M., Ruano, D., Vizuete, M., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100066 · Cited by 98 · cited 2×
“…lines expressing human APP and/or PS1 mutations as a model for amyloidosis, a depletion in CALRET- and PV immunoreactivity was observed in the hippocampus, as determined by densitometry (Popović et al., 2008) and stereology (Baglietto-Vargas et al., 2010; Takahashi et al., 2010), respectively.”
MethodGarrido Sanabria, E. R., Castañeda, M. T., Banuelos, C., Perez-Cordova, M. G., Hernandez, S., & Colom, L. V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.057 · Cited by 68 · cited 1×
“On the other hand, it has been shown that hippocampal hyperexcitability can predominantly lead to the degeneration of GABAergic septal neurons (Garrido Sanabria et al., 2006).”
BackgroundPopović, M., Caballero-Bleda, M., Kadish, I., & Van Groen, T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.023 · Cited by 38 · cited 2×
“…lines expressing human APP and/or PS1 mutations as a model for amyloidosis, a depletion in CALRET- and PV immunoreactivity was observed in the hippocampus, as determined by densitometry (Popović et al., 2008) and stereology (Baglietto-Vargas et al., 2010; Takahashi et al., 2010), respectively.”
MethodCognitive impairment in mice over-expressing γ-aminobutyric acid transporter I (GAT1)
Hu, J.-H., Ma, Y.-H., Jiang, J., Yang, N., Duan, S.-H., Jiang, Z.-H., Mei, Z.-T., Fei, J., & Guo, L.-H. (2004) · NeuroReport · doi:10.1097/00001756-200401190-00003 · Cited by 26
Cited by
Hijazi, S., Heistek, T. S., Scheltens, P., Neumann, U., Shimshek, D. R., Mansvelder, H. D., Smit, A. B., & van Kesteren, R. E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0483-4 · Cited by 216
Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
Govindpani, K., Calvo-Flores Guzmán, B., Vinnakota, C., Waldvogel, H., Faull, R., & Kwakowsky, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081813 · Cited by 208
GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
Xu, Y., Zhao, M., Han, Y., & Zhang, H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00660 · Cited by 203
Born, H. A., Kim, J.-Y., Savjani, R. R., Das, P., Dabaghian, Y. A., Guo, Q., Yoo, J. W., Schuler, D. R., Cirrito, J. R., Zheng, H., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5171-13.2014 · Cited by 178
Bao, H., Asrican, B., Li, W., Gu, B., Wen, Z., Lim, S.-A., Haniff, I., Ramakrishnan, C., Deisseroth, K., Philpot, B., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.003 · Cited by 151
Metadata
- Authors
- Loreth, D., Ozmen, L., Revel, F. G., Knoflach, F., Wetzel, P., Frotscher, M., Metzger, F., & Kretz, O.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 47
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2010374900
- Cited by
- 57
- References
- 23
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.